| Literature DB >> 30622327 |
Lettie E Rawlins1,2, Hannah Jones1, Olivia Wenger3, Myat Aye1, James Fasham1,2, Gaurav V Harlalka1, Barry A Chioza1, Alexander Miron4, Sian Ellard1, Matthew Wakeling1, Andrew H Crosby5, Emma L Baple6,7.
Abstract
The centrosomal protein 55 kDa (CEP55 (OMIM 610000)) plays a fundamental role in cell cycle regulation and cytokinesis. However, the precise role of CEP55 in human embryonic growth and development is yet to be fully defined. Here we identified a novel homozygous founder frameshift variant in CEP55, present at low frequency in the Amish community, in two siblings presenting with a lethal foetal disorder. The features of the condition are reminiscent of a Meckel-like syndrome comprising of Potter sequence, hydranencephaly, and cystic dysplastic kidneys. These findings, considered alongside two recent studies of single families reporting loss of function candidate variants in CEP55, confirm disruption of CEP55 function as a cause of this clinical spectrum and enable us to delineate the cardinal clinical features of this disorder, providing important new insights into early human development.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30622327 PMCID: PMC6420058 DOI: 10.1038/s41431-018-0306-0
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246